G6PD Deficiency: Triggers, Jaundice, and Safe Medication Choices

G6PD deficiency is a common inherited red blood cell enzyme condition that can lead to sudden red cell breakdown after certain triggers. With diagnosis, trigger awareness, and careful medication choices, most people live healthy, active lives.

Overview

G6PD deficiency, also called glucose-6-phosphate dehydrogenase deficiency, is an inherited condition that affects red blood cells. The G6PD enzyme helps protect these cells from oxidative stress, a type of chemical stress that can damage cell membranes. When enzyme activity is low, red blood cells may break down faster than the body can replace them, especially after certain triggers.

This breakdown is called hemolysis. It can lead to hemolytic anemia, jaundice, and dark urine. Many people with G6PD deficiency have no symptoms most of the time and only discover the condition after an episode of jaundice, anemia, newborn screening, family testing, or testing before certain medicines.

G6PD deficiency is usually inherited through the X chromosome. It is more often recognized in males, but females can also be affected, including some who have significant symptoms. The condition is seen worldwide and is more common in people with family origins from Africa, the Mediterranean, the Middle East, and parts of Asia.

Symptoms and Signs of Hemolysis

Most people with G6PD deficiency feel well until a trigger causes red blood cells to break down. Symptoms may appear within hours to a few days after an infection, a high-risk food, or an unsafe medicine. The severity varies widely depending on the person’s enzyme level, the trigger, and overall health.

Possible symptoms include sudden tiredness, weakness, dizziness, headache, fast heartbeat, shortness of breath with activity, pale skin, yellowing of the skin or eyes, and back or abdominal discomfort. Dark tea-colored or cola-colored urine can occur when hemoglobin from broken red blood cells is cleared through the kidneys.

• Jaundice means a yellow color in the eyes or skin caused by increased bilirubin.
• Anemia means the blood has fewer healthy red blood cells to carry oxygen.
• Hemolysis means red blood cells are breaking apart earlier than normal.

In newborns, G6PD deficiency may present mainly as jaundice in the first days of life. Newborn jaundice is common for many reasons, but babies with G6PD deficiency may need closer monitoring because bilirubin can rise quickly in some cases.

Triggers: Foods, Infections, Chemicals, and Medicines

The most important day-to-day management step is knowing and avoiding triggers. Infections are among the most common causes of hemolysis in people with G6PD deficiency. Fever, bacterial or viral illness, and inflammation can increase oxidative stress, even when no medicine is involved.

Fava beans are a well-known food trigger and should generally be avoided by people with G6PD deficiency. This reaction is sometimes called favism. Some people are also advised to avoid close exposure to naphthalene, a chemical found in some mothballs and deodorizing products, because it can trigger hemolysis if inhaled or swallowed, especially by children.

Certain medicines can be unsafe because they increase oxidative stress in red blood cells. Examples that often require avoidance or specialist supervision include primaquine and tafenoquine for malaria, dapsone, rasburicase, methylene blue, nitrofurantoin, phenazopyridine, and some sulfonamide antibiotics. Some drug lists also classify medicines by risk level rather than as simply safe or unsafe, because risk can depend on dose, duration, and the person’s G6PD variant.

Patients should not stop a prescribed medicine without speaking to a doctor, but they should tell every clinician, dentist, pharmacist, and emergency care team that they have G6PD deficiency. Carrying a medical alert card or a phone note with the diagnosis and known unsafe medicines can help prevent avoidable exposures.

Jaundice and Newborn Care

Jaundice happens when bilirubin builds up in the blood. Bilirubin is produced when red blood cells are naturally broken down, and levels can rise when hemolysis occurs. In older children and adults, jaundice from G6PD-related hemolysis is often accompanied by dark urine, fatigue, and signs of anemia.

In newborns, jaundice is assessed by age in hours, bilirubin level, gestational age, feeding, weight change, and other risk factors. Babies with G6PD deficiency may require closer follow-up after birth, even if they initially look well. Parents should seek medical advice if yellowing spreads, the baby feeds poorly, seems unusually sleepy, has a high-pitched cry, or has fewer wet diapers than expected.

Treatment for newborn jaundice may include careful feeding support, repeated bilirubin checks, and phototherapy. Phototherapy uses special light to help the baby’s body process bilirubin. In rare severe cases, more intensive hospital treatments may be needed, but early recognition usually allows jaundice to be managed effectively.

Diagnosis and Testing

G6PD deficiency is diagnosed with a blood test that measures G6PD enzyme activity in red blood cells. Testing may be ordered after unexplained hemolytic anemia, jaundice, a family history, or before certain high-risk medicines. In some countries and regions, newborn screening programs include G6PD testing, especially where the condition is common.

Timing matters. During or soon after a hemolytic episode, the oldest and most enzyme-deficient red blood cells may have already been destroyed, leaving younger cells that show higher enzyme activity. This can occasionally make a test look normal or less abnormal than expected. If clinical suspicion remains, doctors may repeat testing after recovery.

Additional tests during a suspected hemolytic episode may include a complete blood count, reticulocyte count, bilirubin, lactate dehydrogenase, haptoglobin, kidney function tests, and a urine test. Genetic testing may be useful in selected cases, such as complex family counseling, unclear enzyme results, or evaluation of female patients whose enzyme levels can be harder to interpret.

Treatment Options

There is no routine daily cure needed for most people with G6PD deficiency. Management focuses on avoiding triggers, treating infections promptly, and supporting the body during any hemolytic episode. Many mild episodes improve after the trigger is removed and the person is monitored by a healthcare professional.

If hemolysis occurs, treatment depends on severity. Doctors may recommend hydration, rest, monitoring of hemoglobin and bilirubin, and treatment of the underlying infection or condition. In more significant anemia, hospital care, oxygen support, or a blood transfusion may be necessary. Kidney function may also be monitored if urine is very dark or the person is dehydrated.

Medication choices should be individualized. Common medicines such as paracetamol or acetaminophen are often considered acceptable at recommended doses, but patients should still follow a clinician’s advice and avoid exceeding labeled or prescribed amounts. Antibiotics, malaria medicines, urinary medicines, and some pain medicines require careful selection because safer alternatives are often available.

People with confirmed G6PD deficiency should ask their doctor or pharmacist to review all prescription medicines, over-the-counter products, herbal supplements, and travel medicines. This is especially important before malaria prevention or treatment, cancer therapy, treatment for urinary symptoms, or emergency procedures.

Prevention and Self-care

Prevention begins with education. Patients and families should learn the person’s diagnosis, likely triggers, and what symptoms might indicate hemolysis. Keeping a written list of medicines to avoid and medicines previously tolerated can be helpful, but it should be updated by a healthcare professional because recommendations may change over time.

Practical steps include avoiding fava beans, keeping mothballs and chemical deodorizers away from children, seeking timely care for fever or infection, and checking with a doctor before starting new medication. Families should inform schools, caregivers, and sports teams when a child has G6PD deficiency so that symptoms after illness or medication are not overlooked.

A healthy lifestyle also supports recovery and overall blood health. Balanced nutrition, good hydration during illness, and avoiding unnecessary self-medication are sensible measures. Iron supplements are not automatically helpful for G6PD-related anemia unless iron deficiency is proven, so supplements should be used only when recommended.

When to See a Doctor

Medical advice is recommended if a person with G6PD deficiency develops jaundice, dark urine, unusual tiredness, paleness, shortness of breath, fainting, or a fast heartbeat, especially after a new medicine, infection, or possible trigger exposure. These symptoms do not always mean a severe problem, but they should be assessed so anemia and bilirubin levels can be checked.

Urgent care is appropriate for severe weakness, confusion, chest pain, breathing difficulty, very dark urine with reduced urination, or rapidly worsening jaundice. Newborns with yellowing of the skin or eyes should be assessed promptly, particularly if they are feeding poorly or are unusually sleepy.

Before surgery, travel, malaria prevention, or treatment for a serious infection, patients should remind the medical team about G6PD deficiency. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals can evaluate and treat blood disorders, including G6PD deficiency, for international patients who need coordinated care.

Frequently asked questions

Is G6PD deficiency a lifelong condition?

Yes. G6PD deficiency is inherited and does not go away, but many people never have serious symptoms. The main goal is to avoid known triggers and seek medical advice early if signs of hemolysis occur.

Can a person with G6PD deficiency take pain relievers?

Some pain relievers are generally used safely at recommended doses, but the best choice depends on age, health history, and the reason for pain. People with G6PD deficiency should ask a doctor or pharmacist before using new over-the-counter medicines, especially if they are ill or taking other drugs.

Why are fava beans a problem in G6PD deficiency?

Fava beans contain substances that can increase oxidative stress in red blood cells. In susceptible people, this can trigger hemolysis, jaundice, and anemia. For this reason, people with confirmed G6PD deficiency are usually advised to avoid fava beans.

Does G6PD deficiency always cause jaundice?

No. Many people with G6PD deficiency have normal skin and eye color most of the time. Jaundice may appear during hemolysis or in newborns when bilirubin rises, and it should be assessed by a healthcare professional.

Can women have G6PD deficiency?

Yes. Although G6PD deficiency is more often recognized in males because of X-linked inheritance, females can also have low enzyme activity and symptoms. Testing may be more complex in females, so repeat enzyme testing or genetic testing may sometimes be considered.

What should patients tell healthcare providers before receiving medication?

They should clearly state that they have G6PD deficiency and mention any previous reactions to medicines, foods, or chemicals. It is helpful to carry a medical alert card or phone note and ask the doctor or pharmacist to check medication safety before treatment begins.

References

• World Health Organization
• Centers for Disease Control and Prevention
• American Academy of Pediatrics
• British Society for Haematology
• MedlinePlus

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.